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Abstract 
This systematic review and meta-analysis determined the impact of structured exercise 
training, and the influence of associated weight loss, on intrahepatic triglyceride (IHTG) in 
individuals with non-alcoholic fatty liver disease (NAFLD). It also examined its effect on 
hepatic insulin sensitivity in individuals with or at increased risk of NAFLD. Analyses were 
restricted to studies using magnetic resonance spectroscopy or liver biopsy for the 
measurement of IHTG and isotope-labelled glucose tracer for assessment of hepatic insulin 
sensitivity. Pooling data from 17 studies (373 exercising participants), exercise training for 
one to 24 weeks (mode: 12weeks) elicits an absolute reduction in IHTG of 3.31% (95% CI: -
4.41 to -2.22%). Exercise reduces IHTG independent of significant weight change (-2.16 [-
2.87 to -1.44]%), but benefits are substantially greater when weight loss occurs (-4.87 [-6.64 
to -3.11]%). Furthermore, meta-regression identified a positive association between 
percentage weight loss and absolute reduction in IHTG (β = 0.99 [0.62 to 1.36], P<0.001). 
Pooling of six studies (94 participants) suggests that exercise training also improves basal 
hepatic insulin sensitivity (mean change in hepatic insulin sensitivity index: 0.13 [0.05 to 
0.21] mg•m-2•min-1 per μU•mL-1), but available evidence is limited and the impact of exercise 
on insulin-stimulated hepatic insulin sensitivity remains unclear.  
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Introduction 
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease 
worldwide (1) and a prominent risk factor for cardiovascular disease, chronic kidney disease 
and type 2 diabetes mellitus (T2DM) (2). Insulin resistance promotes hepatic lipid 
accumulation, which is most commonly assessed via the measurement of intrahepatic 
triglyceride (IHTG) (3–6). The associated accumulation of lipid intermediates, such as 
diacylglyerol (DAG), may in turn perpetuate insulin resistance (3–6); providing a mechanistic 
link between NAFLD and impaired metabolic regulation. As such, strong associations exist 
between excess IHTG and insulin resistance in multiple tissues, including the liver (3,7,8). 
Defects in hepatic insulin signalling contribute to elevated endogenous glucose production 
(EGP) which is integral to the pathophysiology of impaired glucose regulation and T2DM 
(6,9,10). 
 
Prompted by reports that exercise training has the capacity to reduce IHTG in the absence of 
weight loss (11,12), the independent effects of exercise in the treatment of NAFLD have been 
examined (13–17). These reviews confirm the ability of exercise to reduce IHTG without 
significant weight change; however, the importance of the exercise-related energy deficit and 
subsequent weight loss has not been investigated thoroughly. Acute and sustained energy 
restriction and weight loss potently reduces IHTG in individuals with NAFLD (18,19) and 
therefore logic dictates that weight loss associated with exercise training would be an 
important mediator of the IHTG response to exercise training. This issue has practical 
implications for the prescription of exercise in the management of NAFLD and thus deserves 
explicit attention.  
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Previous reviews highlight a range of different methods to estimate IHTG, including non-
invasive imaging by ultrasound (US) or computed tomography (CT), proton magnetic 
resonance spectroscopy (1H-MRS) and invasive liver biopsy. The inclusion of multiple 
methods within these reviews has the benefit of broadening study eligibility and thus 
increasing pooled participant sample size. However, it also adds an additional source of 
heterogeneity. US and CT are also limited by a lack of sensitivity to detect mild-to-moderate 
accumulation of IHTG and to quantify subtle changes resulting from experimental 
interventions (20). 1H-MRS has much greater precision (21), making it a more suitable 
method for experimental research, whilst the necessity to characterise histological features 
beyond steatosis make liver biopsy the standard tool in clinical practice (22,23).  
 
The effect of exercise training on hepatic insulin sensitivity has not been reviewed. A number 
of indices exist which assess insulin resistance using simple circulating biomarkers (24) but 
stable or radioactive isotope-labelled tracers are required to obtain the most accurate 
measurement of insulin sensitivity in individual tissues (25). Glucose tracers can be used to 
quantify EGP (primarily attributed to hepatic glucose production) (10) to accurately assess 
hepatic insulin sensitivity in the basal (fasted) and insulin-stimulated (post-prandial) states; 
using the hepatic insulin sensitivity index (HISI) and percentage suppression of EGP 
(%EGPsupp) by low-dose insulin infusion, respectively (24,26). 
 
This systematic review and meta-analysis had two primary aims. First, we investigated the 
effects of structured exercise training on IHTG in individuals with NAFLD, with a particular 
focus on the impact of concurrent weight loss, whilst restricting analyses to studies using 1H-
MRS and liver biopsy. Second, we explored the effects of exercise training on basal and 
insulin-stimulated hepatic insulin sensitivity. 
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Methods 
The current systematic review and meta-analysis (PROSPERO ID: CRD42014007268) was 
conducted in accordance with the “Cochrane handbook for systematic reviews of 
interventions” and PRISMA guidelines (27,28). All aspects of the literature search, study 
selection and risk of bias assessment were completed by two researchers independently (JS 
and JK/SW). Data extraction and analysis were performed by a single researcher (JS) before 
being checked, independently, by another (extraction: JK; analysis: DB/LG). 
 
Primary outcomes 
This review had two outcome measures: 
 IHTG 
 Hepatic insulin sensitivity (basal and insulin-stimulated) 
 
Eligible studies were restricted to those using 1H-MRS or liver biopsy for the measurement of 
IHTG, and using isotope-labelled glucose tracer to quantify EGP in the fasted state and 
following low-dose (≤ 20 mU•m-2•min-1 or ≤ 0.5 mU•kg-1•min-1) insulin infusion, for the 
calculation of HISI and %EGPsupp, respectively. 
 
Literature search 
Six electronic online databases (EMBASE, MEDLINE, PubMed, Scopus, Sport Discus and 
Web of Science) were searched from inception to July 2017 using terms related to exercise, 
IHTG and hepatic insulin sensitivity. The full list of search terms can be found in 
supplementary methods. Reference lists of all included manuscripts were screened for further 
eligible studies.  
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Study selection 
Human experimental studies written in the English language were included. Conference 
abstracts were considered but underwent the same eligibility and risk of bias assessments as 
full articles. Eligible studies were those in which participants with overweight or obesity 
completed an exercise training programme of at least three exercise sessions. All types of 
study design were considered. Studies investigating changes in IHTG were only eligible if 
participants had diagnosed NAFLD or where baseline characteristics met diagnostic criteria 
(IHTG > 5% in the absence of secondary steatogenic sources, including excessive alcohol 
intake and viral infection (22,23)). NAFLD was not an inclusion criterion for studies 
investigating changes in hepatic insulin sensitivity as it became apparent that very few studies 
have examined this outcome exclusively in this patient group and a number of otherwise 
eligible studies did not measure IHTG. Studies investigating exercise in combination with 
dietary intervention were eligible only when data were available for matched, independent 
groups prescribed exercise training with or without diet. In studies measuring hepatic insulin 
sensitivity, it was essential that participants refrained from strenuous exercise for at least 48 
hours before assessments (29). 
 
Data extraction 
Descriptive information (first author and year of publication), details of study design, 
participant and intervention characteristics and outcome data were extracted from eligible 
manuscripts. Outcome data were extracted as mean change and standard deviation from pre- 
to post-intervention for all exercise groups, as well as for the control groups of randomised 
controlled trials (RCTs). Where possible, outcome data presented in alternative forms were 
converted as outlined in supplementary methods. When incomplete or insufficient data were 
reported, the authors were contacted. If the required data were unavailable the study was 
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removed. When characteristics of exercise interventions (such as the frequency, intensity or 
duration of exercise sessions) progressed over the course of a programme, a weighted mean 
was calculated. Further details of data extraction can be found in supplementary methods. 
 
A number of variations of HISI exist, including the statistical inverse (the hepatic insulin 
resistance index; HIRI). Studies reporting these alternatives were included in qualitative 
review but were only included in quantitative meta-analysis when raw data were available for 
the calculation of HISI as originally described (24): 
 
 1000 / (EGP [mg•m-2•min-1] x fasted plasma insulin [µU•mL-1]) 
 
Studies that reported EGP and fasted plasma insulin (FPI) separately were also considered, 
but were excluded from all analyses unless raw data were available for the calculation of 
HISI as above. Mean values of EGP and FPI were not combined. Similarly, when study 
design allowed the calculation of %EGPsupp but it was not reported, raw data were requested. 
 
Risk of bias assessment 
Studies were assessed for risk of bias using a modified Downs and Black scale (30). This 
checklist includes 26 items divided into categories of (i) reporting, (ii) external validity, (iii) 
internal validity – bias, (iv) internal validity – confounding and (v) power. Modifications 
made to the original scale are outlined in supplementary methods. Consensus between the 
two independent assessors (JS/JK) was ensured. Publication bias was assessed using funnel 
plots. 
 
Meta-analyses 
Page 10 of 43 
 
Pooled characteristics of study participants are presented as weighted means, accounting for 
differences in sample size, along with the range. Quantitative analysis was conducted using 
commercially available software (Stata IC, Version 14.1, StataCorp LP, Texas, USA). Pooled 
mean differences with 95% confidence intervals (95% CI) were calculated for primary 
outcomes using random effects models and heterogeneity was assessed quantitatively using 
the I2 statistic. 
 
Where possible, primary outcomes were analysed in two ways: 
Within-group analysis: The change from pre- to post-intervention measurements in all 
exercise groups of all eligible studies. 
Between-group analysis: The difference in the change from pre- to post-intervention 
between exercise and control groups in RCTs only. 
 
In RCTs with multiple exercise groups, groups were combined as outlined in supplementary 
methods. When groups were not suitable to be combined (for example, aerobic and resistance 
exercise training groups), data from the aerobic intervention group was used. 
 
Subgroup analyses and meta-regression 
Subgroup analyses were performed to investigate whether the presence of significant weight 
loss (defined as a statistically significant reduction in body weight from pre- to post-
intervention) explained heterogeneity in the response of IHTG to exercise training. The 
influence of the exercise mode (aerobic, high-intensity interval (HIIT), resistance or 
combined aerobic/HIIT-plus-resistance training) was also investigated, as was the exercise 
intensity (moderate- or high-intensity) of aerobic and HIIT interventions. Exercise intensity 
was categorised according to published criteria (31), which are summarised in Table 1. One 
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study (32) prescribed exercise relative to maximal workload. This study was categorised 
using the same percentage categories as those of V̇O2 peak. Meta-regression was also 
performed to explore the effects of intervention duration and the magnitude of body weight 
change on changes in IHTG. All subgroup analyses and meta-regressions were performed 
using the mean change from pre- to post-training in all exercise groups of eligible studies. 
Secondary analyses of hepatic insulin sensitivity were not performed due to the limited 
number of studies identified. 
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Results 
Literature search 
Figure 1 presents a flowchart of the literature search and study selection processes. To 
summarise, 20,055 records were returned by the six online databases, along with five from 
reference lists of eligible manuscripts. Of these, 111 manuscripts underwent full assessment 
and 21 were eligible for inclusion (20 for meta-analyses). Twenty were complete articles and 
one was a conference abstract, although the latter has since been published in full (33). Table 
2 presents an overview of eligible studies, but readers are directed to supplementary materials 
(Tables S1 to S3) for more detailed description. 
 
Insert Figure 1 here 
 
Risk of bias assessment 
Full results of the risk of bias assessment can be found in supplementary materials (Table S4). 
Studies scored highly on items related to reporting, with the exception of reporting adverse 
events, and internal validity. Seven studies (11,18,34–38) blinded the investigators 
performing assessments of IHTG, but allocation concealment was only performed in three 
out of 10 RCTs (34,37,38). Conversely, studies scored poorly in relation to external validity, 
primarily due to an inability to determine whether recruited participants were representative 
of the entire population or of those who were approached to participate. Funnel plots 
suggested minimal evidence of publication bias (Figure S1), although the plot of all 
intervention groups investigating IHTG suggested a small bias towards studies reporting 
small effects. This would, if anything, result in an attenuated pooled effect. Seven studies 
recorded energy intake using self-reported food diaries (11,35,39–42) or a validated food 
frequency questionnaire (37). All of these reported no change in energy intake from pre- to 
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post-intervention, although one (41) reported a small increase in carbohydrate intake in 
participants completing a high-intensity, low-volume exercise programme. One study (43) 
prescribed a weight maintenance diet to participants. A further 10 studies instructed 
participants to maintain their dietary habits throughout the duration of study involvement 
without formally monitoring diet (18,33,34,38,44–49), whilst three manuscripts make no 
reference to the control of dietary intake (12,32,36). 
 
The effects of exercise training on IHTG 
Eighteen studies reported the effects of exercise training on IHTG (11,12,18,33–37,39–
42,44–48) (Table 2). Only one of these used paired liver biopsy (18), reporting no significant 
effect of 6-months resistance exercise on the percentage of hepatocytes affected by steatosis 
in individuals with NAFLD. The remaining 17 studies used 1H-MRS to measure IHTG so, to 
reduce heterogeneity, only these studies were included in subsequent meta-analyses. These 
studies contained 19 exercise groups and a combined total of 373 participants (male: 151 
[40.5%]; female: 182 [48.8%]; data not reported: 40 [10.7%]). Participants had a weighted 
mean age of 50 [range 15.5 to 60] years and were overweight or obese (body mass index: 
30.6 [27.8 to 37.1] kg•m-2; body fat percentage: 35.6 [28.7 to 43.7] %; waist circumference: 
101.2 [95.2 to 111.9] cm). Participants were reported as sedentary and/or inactive and had 
low aerobic capacity (peak oxygen uptake: 25.2 [21.8 to 38.7] ml•kg-1•min-1). Two studies 
actively recruited individuals with T2DM (34) or dysregulated glucose metabolism (37), 
whilst the mean baseline characteristics of seven other studies (11,36,38,39,46–48) met 
diagnostic criteria for impaired fasted glucose (weighted mean fasted glucose: 5.61 [4.09 to 
6.80] mmol•L-1) (50). The weighted mean IHTG at baseline was 15.8 [6.9 to 23.1] %.  
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Interventions included aerobic (n = 11), HIIT (n = 3), resistance (n = 2), combined 
aerobic/HIIT-plus-resistance (n = 2) and acceleration/vibration (n = 1) exercise training, 
ranging from seven days to 24 weeks (mode: 12 weeks). Session frequency ranged from two 
to seven times per week (mode: three times per week) for 30 to 60 minutes. Six aerobic 
interventions used moderate-intensity exercise whilst the remaining five, along with all of the 
HIIT interventions, were categorised as high-intensity.  
 
Ten of the included studies were RCTs, containing a combined 283 and 169 participants in 
exercise and control groups, respectively (Table 2). Pooled participant and intervention 
characteristics of RCTs only can be found in supplementary materials (Tables S5 and S6). 
There were no significant differences between the pooled characteristics of RCTs and those 
of all eligible studies (P ≥ 0.13). Participants in RCT control groups were instructed to 
maintain standard care (n = 5) or habitual lifestyle activities (n = 1), prescribed a low-
intensity stretching programme (n = 2) or attended sessions providing education on the health 
benefits of exercise (n = 2). 
 
Fourteen of the 17 studies reported a statistically significant benefit of exercise on IHTG 
either within-group (33,37,40,42,44), between-group (11,12), or both (34–36,38,41,47,48). In 
the two studies with multiple exercise groups, exercise elicited a significant reduction in both 
groups (38,41). One RCT reported a significant reduction from baseline, but this was not 
significant when compared to the change in the control group (40). Of the three studies that 
reported no benefit of exercise, two were short interventions (performing exercise on seven 
consecutive days) (39,46), whilst the other was a resistance exercise programme in obese 
adolescents (45). 
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When data from pre- to post-exercise in all interventions were pooled, a statistically 
significant benefit of exercise training was found (Figure 2), but high heterogeneity was also 
apparent. In a sensitivity analysis of RCTs only, the significant benefit of exercise was 
strengthened (mean difference in change between groups [95% CI]: -3.61 [-4.68 to -2.54] %; 
Figure S2), and results were highly homogeneous (I2 < 0.1%, P = 0.84). Therefore, to allow 
the inclusion of maximum data, subgroup analyses and meta-regressions were performed 
using the within-group change in all interventions.  
 
Insert Figure 2 here 
 
Exercise training significantly reduced IHTG in the absence of weight loss. However, when 
significant weight loss occurred, the pooled effect was substantially greater (Figure 3). 
Furthermore, meta-regression displayed a significant positive relationship between the 
change in body weight (relative to baseline) and the absolute change in IHTG (β = 0.99 [95% 
CI: 0.62 to 1.36], P < 0.001; Figure S3).  A significant relationship was also apparent 
between intervention duration and change in IHTG (β = -0.27 [95% CI: -0.35 to -0.19], P < 
0.001; Figure S4), suggesting that as the duration of intervention increases, so does the 
magnitude of reduction in IHTG. The duration of interventions that elicited significant weight 
loss versus those that did not were similar (median [range]: 12 [8 to 24] vs. 12 [1 to 16] 
weeks), but bivariate Pearson’s correlation analysis showed a significant positive relationship 
between the duration of intervention and magnitude of weight loss elicited (r2 = 36%, P < 
0.01). 
 
Insert Figure 3 here 
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Figure 2 displays the mean change from baseline in IHTG for all interventions categorised by 
exercise type. The pooled effect on IHTG for aerobic exercise interventions was greater than 
that for each other mode of exercise, as well as the pooled mean for all interventions. 
However, the high prevalence of aerobic interventions in comparison to other types of 
intervention should be noted. When interventions were grouped according to exercise 
intensity, the pooled effect for moderate-intensity interventions was greater than that of the 
high-intensity exercise programmes (-4.82 [-7.00 to -2.65] %, I2 = 75.5%, P = 0.001 vs. (-
2.89 [-4.25 to -1.53] %, I2 = 73.2%, P < 0.001). The intervention duration of the moderate 
and high-intensity interventions were similar (median [range]: 14 [4 to 24] vs. 12 [1 to 24] 
weeks). 
 
Overview of studies investigating the effects of exercise on hepatic insulin sensitivity 
Eight studies, containing a total of 10 exercise groups, reported the effects of exercise 
training on hepatic insulin sensitivity (18,32,33,35,43,45,49,51) (Table 2). Four studies 
reported HISI (33,43–45), although three presented EGP (and thus HISI) in different units to 
those outlined above. Two studies reported HIRI (18,35). Four studies were able to provide 
raw data for the re-calculation of HISI (18,35,44,45), along with two that reported EGP and 
FPI separately (32,49). As such, seven studies (eight exercise groups) were included in meta-
analysis of changes in HISI with exercise training. Only two of these (35,49) were RCTs with 
a non-intervention/standard care control group (containing a combined 22 and 14 participants 
in exercise and control groups, respectively) so only within-group analysis was conducted. 
Three studies also reported %EGPsupp with low-dose insulin infusion (33,35,49) but, due to 
this limited number, meta-analysis was not performed. Seven further studies were found that 
utilised a study design allowing the calculation of at least one of HISI or %EGPsupp, but 
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neither were reported (52–58). Whilst the authors of five of these studies kindly replied to 
requests for raw data, none were able to provide it. 
 
The effects of exercise training on basal hepatic insulin sensitivity  
The study that was excluded from meta-analysis of changes in HISI reported a tendency for a 
reduction in HIRI in obese adolescent girls following 12 weeks of resistance exercise training, 
but not after 12 weeks of moderate- to high-intensity aerobic exercise (43). The remaining 
eight exercise groups were pooled and had a combined total of 105 participants (male: 84 
(80%); female: 20 (19%); data not available: 1 (1%)). Participants had a weighted mean age 
of 43 [range 15.5 to 59] years and, as per study selection criteria, were overweight or obese 
(body mass index: 31.3 [27.6 to 35.3] kg•m-2; body fat percentage: 34.0 [25.5 to 40.8] %). 
Participants were reported as sedentary and/or inactive and had low aerobic capacity 
(maximal or peak oxygen uptake: 24.7 [21.6 to 32.0] ml•kg-1•min-1). Five studies (five 
exercise groups) were conducted in individuals with diagnosed NAFLD or in those with 
baseline characteristics that met diagnostic criteria as outlined above (18,33,35,45,51). One 
study included separate groups of patients with impaired fasted glucose and T2DM (32) but, 
according to mean baseline characteristics, all other studies recruited individuals with normal 
fasted glycaemia (weighted mean fasted glucose for all studies was 5.36 [4.70 to 9.00] 
mmol•L-1) (50). The weighted mean HISI at baseline was 0.99 [0.58 to 2.09] mg•m-2•min-1 
per μU•mL-1.  
 
Studies included aerobic (n = 3), HIIT (n = 1), resistance (n = 2) and combined (n = 2) 
exercise interventions for six (n = 2), 12 (n = 5) or 24 (n = 1) weeks. Participants exercised on 
two to four days per week with sessions ranging from 20 to 60 minutes. One aerobic 
intervention, and the aerobic component of the combined exercise programmes, utilised 
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moderate-intensity exercise, whilst the remaining aerobic interventions and the HIIT 
intervention were categorised as high-intensity.  
 
Two of the eight exercise groups displayed a statistically significant improvement in HISI 
with exercise, both of which were in adolescents (45,51). One study reported a tendency for 
reduced HIRI after exercise training, but this effect was statistically significant when HISI 
was re-calculated as above. Neither RCT reported a significant difference between exercise 
and control groups (35,49). However, when data were pooled, a statistically significant 
benefit of exercise was found (Figure 4). Based on the weighted mean HISI at baseline, this 
pooled effect represents a relative improvement of approximately 13%. Two studies in obese 
adolescents reported a reduction in basal EGP after aerobic or resistance exercise training 
(45,51), but EGP was unaffected in all other studies. In contrast, FPI was significantly 
reduced in five of the exercise groups (32,33,35,51), whilst the mean reduction in another (18) 
approached statistical significance. One study (35) reported a statistically significant 
reduction in body weight from pre- to post-exercise training (2.5%) but this was not 
associated with an improvement in HISI. Another study (18) reported a mean reduction in 
body weight of similar magnitude (2.6%) which, although not statistically significant, was 
associated with a significant improvement in HISI. 
 
Insert Figure 4 here 
 
The effects of exercise training on insulin-stimulated hepatic insulin sensitivity 
Participant and intervention characteristics for the three studies examining the effects of 
exercise on %EGPsupp can be found in supplementary materials (Tables S2 and S3). The two 
RCTs that reported HISI also reported %EGPsupp. One RCT reported a significant 
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improvement in %EGPsupp, compared to the control group, after six weeks of aerobic exercise 
training, despite no change in total body weight or IHTG (49). In contrast, %EGPsupp was 
reportedly unaffected by either twelve weeks of aerobic training (35) or six weeks of HIIT 
(33).  
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Discussion 
The prominent findings of this review are that structured exercise training, independent of 
dietary intervention, reduces IHTG in individuals with NAFLD. Importantly, whilst this 
effect is apparent without weight loss, the magnitude of reduction increases in direct 
proportion to the amount of weight loss induced by the intervention. Furthermore, our 
analyses indicate that exercise training for six to 24 weeks may also improve basal hepatic 
insulin sensitivity by approximately 13%. 
 
Previous reviews report that exercise training significantly reduces IHTG with a moderate to 
large pooled effect size (13,15,17). The restriction of the current meta-analysis to a single 
technique (1H-MRS) allowed us to report this pooled effect as the absolute mean difference 
and our findings suggest that exercise training for between one and 24 weeks (mode 12 
weeks) elicits an absolute reduction in IHTG of approximately 2.2 to 4.7% (mean ~3.5%); re-
enforcing the meaningful therapeutic role of exercise for individuals with NAFLD. An 
important finding to emerge from this meta-analysis is the impact of weight loss as a 
mediator of the reduction in IHTG associated with exercise training interventions. This 
outcome is consistent with previous reviews (59,60), which have highlighted the more potent 
impact of weight loss per se (primarily through dietary energy restriction) than the 
independent effect of exercise in the absence of body weight reduction. Specifically, our data 
show that whilst IHTG is significantly reduced in the absence of exercise-induced weight loss, 
the magnitude of effect is more than two-fold greater when weight loss occurs (-2.16 vs. -
4.87%). Meta-regression suggests that each 1% relative reduction in body weight is 
associated with approximately 1% absolute reduction in IHTG. Interestingly, an almost 
identical relationship can be seen in studies that have examined IHTG responses to short-, 
medium- and long-term dietary energy restriction interventions (61–63). These data therefore 
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illustrate that relative changes in IHTG are several-fold greater than associated alterations in 
body weight regardless of physiological stimulus. This overriding influence of weight loss 
may also explain why previous reviews have not found additive benefits of exercise when 
combined with dietary intervention (13,14). In these scenarios, large energy deficits created 
by dietary modification may dilute the much smaller contribution of exercise (64). 
Consequently, whilst exercise alone may be effective at reducing IHTG, the greatest 
therapeutic benefits will be realised when exercise interventions contribute to weight loss in 
combination with dietary energy restriction.  
 
These findings have direct implications for exercise prescription in NAFLD. Specifically, the 
greatest impact of exercise training on IHTG is likely to occur with exercise that is associated 
with the greatest weight loss (14). Evidence suggests that aerobic exercise interventions 
typically evoke a higher amount of weight loss than anaerobic exercise modalities (65). The 
superiority of aerobic exercise interventions for reducing IHTG in individuals with NAFLD 
is supported by the present results and those of a previous meta-analysis (15). Consequently, 
although resistance exercise training and HIIT promote a reduction in IHTG in patients with 
NAFLD, greater benefits will likely be achieved through continuous aerobic exercise 
protocols such as running, swimming and cycling. 
 
Exercise volume may also be an important variable which helps to explain why our analyses 
documented a larger reduction in IHTG with moderate- compared to high-intensity exercise 
interventions. Specifically, compared with shorter intense bouts of exercise, continuous 
moderate-intensity protocols commonly exhibit a greater total exercise volume and, 
consequently, energy expenditure. This higher level of energy expenditure may elicit a 
greater impact on metabolism, energy balance and IHTG. It is, however, important to 
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consider that exercise-related energy expenditure may not necessarily translate into greater 
total daily energy expenditure (66,67). Furthermore, given the inability to accurately calculate 
exercise-related energy expenditure in our review, further research is needed to investigate 
the precise relationship between exercise-related energy expenditure and IHTG. 
 
Our analyses also demonstrate a significant relationship between the duration of exercise 
interventions and the change in IHTG, and a positive relationship between the duration of 
exercise training and the magnitude of weight loss. Each week of exercise training is 
associated with a reduction in IHTG of approximately 0.27%. Collectively, our findings 
highlight the importance of developing sustainable exercise interventions, which, in 
combination with dietary strategies, may elicit the greatest benefits on IHTG in individuals 
with NAFLD. 
 
The second part of this review examined the influence of exercise training on hepatic insulin 
sensitivity. Hepatic insulin resistance, which is strongly correlated with elevated IHTG 
(3,7,8), contributes to impaired glycaemic control in the pathogenesis of T2DM (6,9,10). We 
assessed the impact of exercise interventions on HISI and %EGPsupp, which are measures of 
hepatic insulin sensitivity in the basal and insulin-stimulated states, respectively. The paucity 
of studies examining these effects meant that our analyses were conducted using any study 
that recruited individuals with overweight or obesity, who are thus at increased risk of 
NAFLD, in addition to studies exclusively in patients with NAFLD. 
 
In total, we identified eight studies (two of which had two exercise groups) which assessed 
the impact of exercise on basal hepatic insulin sensitivity (18,32,33,35,43,45,49,51). Seven 
studies had sufficient data for inclusion in our meta-analysis but only two of which were 
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RCTs. Therefore, our analysis was restricted to within-group changes in eight exercise groups. 
Interestingly, despite only three exercise groups displaying significant improvements in HISI 
from pre- to post- intervention (18,45,51), our pooled analysis identified a statistically 
significant increase of approximately 13%. In adults, basal rates of EGP were unaffected by 
exercise, but this improvement in basal hepatic insulin sensitivity may be reflected by a 
reduction of FPI. The clinical relevance of this magnitude of improvement in basal hepatic 
insulin sensitivity for individuals that are overweight and obese is not immediately clear. 
However, this novel finding suggests that exercise training favourably modifies this 
important parameter in individuals at risk of NAFLD and T2DM.  
 
Three studies reported the effects of exercise on %EGPsupp (33,35,49), two of which were 
RCTs employing aerobic exercise interventions of six and 12 weeks (35,49). While one study 
reported significant improvement in %EGPsupp, no change was reported in the other. 
Therefore, we cannot draw firm conclusions on the impact of exercise training on insulin-
stimulated hepatic insulin sensitivity at this time.  
 
It is notable that we identified a further seven studies whose methods permitted the 
calculation of HISI or %EGPsupp but data weren’t presented or available. Furthermore, when 
hepatic insulin sensitivity was reported, the precise details of the experimental methods 
employed, units used for presentation of outcomes and calculation of indices of hepatic 
insulin sensitivity, varied between studies. This review, therefore, highlights the need for 
greater methodological and reporting consistency when assessing hepatic insulin resistance 
(e.g. standardisation of low-dose insulin infusion when undertaking dual-stepped 
hyperinsulinaemic-euglycaemic clamps and consistent use of units). 
 
Page 24 of 43 
 
Our meta-analysis of the effects of exercise training on IHTG in individuals with NAFLD, 
and the mediating influence of weight loss, is the most precise quantitative synthesis to date. 
Furthermore, this is the first systematic review and meta-analysis assessing the impact of 
exercise interventions on hepatic insulin sensitivity. However, a few important considerations 
are noteworthy. A range of exercise interventions are identified and our analyses of the 
effects of exercise on IHTG display significant heterogeneity. Whilst we explore potential 
sources of this heterogeneity, it is assumed that these studies are suitable for data pooling. 
Secondly, although most included studies attempt to control habitual diet, this is notoriously 
difficult (68) and the potential for dietary changes to influence study outcomes must, 
therefore, be recognised. Additionally, our subgroup analyses investigating the influence of 
weight loss on IHTG were performed with studies categorised according to statistical, rather 
than clinical, significance. This has the potential to exclude studies from the weight loss 
group that demonstrate physiologically relevant, but not statistically significant, weight loss. 
Notably, however, this is unlikely in our analyses because, in the ‘no weight loss’ studies, the 
largest mean relative reduction in body weight after exercise training was 1.2%. Furthermore, 
it assumed that weight loss resulting from exercise training is primarily reflective of a 
reduction in fat mass but some exercise regimens may promote the synthesis of skeletal 
muscle; attenuating any reduction in total body weight. It should also be noted that while a 
reduction in IHTG may be indicative of improved metabolic heath, these may be mediated by 
a reduction in hepatic lipid intermediates rather that IHTG per se (3–5). Finally, the limited 
number of studies investigating hepatic insulin sensitivity means that our findings should be 
taken with caution. Large RCTs are required to further investigate the effects of exercise 
training on hepatic insulin sensitivity, particularly in individuals with NAFLD and T2DM.  
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In conclusion, this systematic review and meta-analysis has shown that exercise training 
reduces IHTG in individuals with NAFLD and, whilst benefits can be realised in the absence 
of weight loss, reductions in IHTG are proportionally related to the magnitude of weight loss 
induced. Furthermore, exercise training may improve basal hepatic insulin sensitivity in 
individuals that are overweight or obese, which may have beneficial implications for the 
management of NAFLD and T2DM. 
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Table 1 – Categories of exercise intensity 
 RPE %HR max %HRR  %V̇O2 peak 
Moderate-intensity 12 – 13 64 – 76 40 – 59 46 – 63 
High-intensity 14 – 17 77 – 95 60 – 89 64 – 90 
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Table 2 - Overview of included studies 
First Author 
(Year of 
Publication) 
Study  
Design 
Sample Size  
(M/F) 
Exercise 
Mode 
Intervention 
Duration 
Session 
Frequency 
Exercise 
Intensity 
(Category) 
Technique 
used for 
Assessment 
of IHTG 
Index of 
Basal 
Hepatic IS 
Originally 
Reported 
Details of Low-
Dose Insulin 
Infusion 
Weight 
Change with 
Exercise 
Training 
(mean % 
change from 
baseline) 
Cassidy  
(2016) 
RCT 
Ex: 12 (10/2) 
Con: 11 (8/3) 
HIIT 12 weeks 
3 times per 
week 
High 1H-MRS - - -1.1 β 
Cuthbertson 
(2016) 
RCT 
Ex: 30 (23/7) 
[12 (8/3/1 NR)] 
Con: 20 (16/4) 
[7 (3/4)] 
Aerobic 12 weeks 
3 – 5 times 
per week 
Moderate 1H-MRS HIRI 
0.3 mU•kg-1•min-1 
for 120 min 
-2.5 α, β 
Hallsworth  
(2011) 
RCT 
Ex: 11 (NR) 
Con: 8 (NR) 
Resistance 8 weeks 
3 times per 
week 
N/A 1H-MRS - - 0.0 
Hallsworth  
(2015) 
RCT 
Ex: 12 (6/6) 
Con: 11 (10/1) 
HIIT 12 weeks 
3 times per 
week 
High 1H-MRS - - -1.6 α, β 
Haus  
(2013) 
Uncontrolled 
Intervention 
Ex: 17 (NR) Aerobic 1 week 
7 times per 
week 
High 1H-MRS - - 0.2 
Hickman  
(2013) 
RCT* 
Ex: 9 (7/2) 
[13 (9/4)] 
Resistance 24 weeks 
3 times per 
week 
N/A Biopsy† HIRI - -2.6 
Houghton  
(2017) 
RCT 
Ex: 12 (7/5) 
Con: 12 (7/5) 
Combined 
(HIIT + 
Resistance) 
12 weeks 
3 times per 
week 
High 1H-MRS - - 1.1 
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Johnson  
(2009) 
RCT 
Ex: 12 (NR) 
Con: 7 (NR) 
Aerobic 4 weeks 
3 times per 
week 
Moderate 1H-MRS - - -0.3 
Keating  
(2015) 
RCT 
Ex1: 12 (6/6) 
Ex2: 11 (5/6) 
Con: 12 (3/9) 
Aerobic 8 weeks 
Ex1: 3 
sessions per 
week 
Ex2: 4 
sessions per 
week 
Ex1: High 
Ex2: Moderate 
1H-MRS - - 
Ex1: -1.2 α, β 
Ex2: -1.5 α, β 
Langleite  
(2016) 
Uncontrolled 
Intervention 
Ex: 11 (11/0) 
Combined 
(Aerobic + 
HIIT + 
Resistance) 
12 weeks 
4 times per 
week 
(1 aerobic,  
1 HIIT, 2 
resistance) 
High 1H-MRS - - -1.2 
Lee  
(2013) 
RCT 
Ex1: [16 (0/16)] 
Ex2: [16 (0/16)] 
Con: [12 (0/12)] 
Ex1: 
Aerobic 
Ex2: 
Resistance 
12 weeks 
3 times per 
week 
High - HISI† - 
Ex1: -1.3 
Ex2: -0.3 
Malin  
(2013) 
Uncontrolled 
Intervention 
Ex: 13 (6/7) Aerobic 1 week 
7 times per 
week 
High 1H-MRS - - 0.6 
Meex  
(2010) 
Uncontrolled 
Intervention 
Ex1: [20 (20/0)] 
Ex2: [17 (17/0)] 
Combined 
(Aerobic + 
Resistance) 
12 weeks 
3 times per 
week  
(2 aerobic, 1 
resistance)  
Moderate - HISI# - 
Ex1: -1.1 
Ex2: -1.0 
Oh  
(2014) 
Uncontrolled 
Intervention 
Ex: 18 (4/14) 
Vibration / 
Acceleration 
6 weeks 
3 times per 
week 
N/A 1H-MRS - - -0.4 α 
Pugh  
(2014) 
RCT 
Ex: 13 (7/6) 
Con: 8 (4/4) 
Aerobic 16 weeks 
3 – 5 times 
per week 
Moderate 1H-MRS - - -2.4 
Sargeant  
(2018) 
Controlled 
Longitudinal 
Intervention 
Ex: 9 (9/0) 
[8 (8/0)] 
HIIT 6 weeks 
3 times per 
week 
High 1H-MRS HISI 
20 mU•m-2•min-1 
for 120 min 
-1.2 
Page 37 of 43 
 
Shojaee-
Moradie  
(2007) 
RCT 
Ex: [10 (10/0)] 
Con: [7 (7/0)] 
Aerobic 6 weeks 
3 times per 
week 
High - HISI# 
0.3 mU•kg-1•min-1 
for 120 min 
-0.8 
Sullivan  
(2012) 
RCT 
Ex: 12 (4/8) 
Con: 6 (1/5) 
Aerobic 16 weeks 
5 times per 
week 
Moderate 1H-MRS - - -0.2 α 
van der 
Heijden  
(2010a)‡ 
Uncontrolled 
Intervention 
Ex: 15 (7/8) 
[15 (7/8)] 
Aerobic 12 weeks 
4 times per 
week 
High 1H-MRS HISI - -0.5 
van der 
Heijden  
(2010b) 
Uncontrolled 
Intervention 
Ex: 7 (NR) 
[12 (6/6)] 
Resistance 12 weeks 
2 times per 
week 
N/A 1H-MRS HISI - 2.6 α 
Zhang  
(2016) 
RCT 
Ex1: 73 (22/51) 
Ex2: 73 (21/52) 
Con: 74 (28/46) 
Aerobic 24 weeks 
5 times per 
week 
Ex1: Moderate 
Ex2: High 
1H-MRS - - 
Ex1: -2.8 α, β 
Ex2: -6.0 α β 
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Table & Figure Legends 
Table 1 – Categories of exercise intensity. Adapted from (31); %HR max: percentage of 
maximal heart rate; %HRR: percentage of heart rate reserve; %V̇O2 peak: percentage of peak 
oxygen uptake; RPE: rating of perceived exertion (69). 
 
Table 2 – Overview of included studies. Sample sizes in squared brackets represent the 
number of participants included in hepatic insulin sensitivity outcomes; Mean changes in 
body weight with exercise are as reported in the original manuscript (α indicates significantly 
different from baseline, β indicates significantly different from non-exercise control group); 
Exercise intensity is categorised according to published criteria (31), which are summarised 
in Table 1; *Study did not include a ‘standard care’ or ‘no intervention’ group, exercise was 
compared with hypocaloric diet; †Study was excluded from one or more meta-analyses - 
Hickman et al (2013) was removed from meta-analyses of changes in hepatic steatosis to 
reduce heterogeneity as it was the only study using liver biopsy to assess IHTG. Lee et al 
(2013) was removed from meta-analysis of changes in basal hepatic insulin sensitivity 
because raw data were not available to allow re-calculation of HISI as outlined by Matsuda 
and DeFronzo (1999); #Published manuscript contained no index of hepatic insulin sensitivity. 
HISI was calculated after authors provided raw data; ‡Manuscript refers to the same study as 
van der Heijden et al (2009); 1H-MRS: Proton magnetic resonance spectroscopy; Con: 
Control group; Ex1/2: Exercise group 1/2; HISI: hepatic insulin sensitivity index; IHTG: 
intrahepatic triglyceride; N/A: not applicable; NR: not reported; RCT: randomised controlled 
trial; %EGPsupp: percentage suppression of endogenous glucose production by low-dose 
insulin infusion. 
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Figure 1 – Flowchart of literature search process. An overview of the literature search and 
study selection process. 
 
Figure 2 – Meta-analysis of the pooled effect of exercise training on IHTG from pre- to 
post-training in all exercise groups of all eligible studies. Studies are grouped by exercise 
mode. IHTG: intrahepatic triglyceride; 95% CI: 95% confidence interval; HIIT: high-
intensity interval training; Combined: combined aerobic- or HIIT-plus-resistance exercise 
training. 
 
Figure 3 – Meta-analysis of the pooled effect of exercise training on IHTG from pre- to 
post-training in all exercise groups of all eligible studies when studies are grouped into 
those that elicited weight loss versus those that did not. IHTG: intrahepatic triglyceride; 
95% CI: 95% confidence interval. 
 
Figure 4 – Meta-analysis of the pooled effect of exercise training on HISI from pre- to 
post-training in all exercise groups of all eligible studies. HISI: hepatic insulin sensitivity 
index; 95% CI: 95% confidence interval; Combined: combined aerobic-plus-resistance 
exercise training; HIIT: high-intensity interval training. 
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